scispace - formally typeset
S

Shyam Kolvekar

Researcher at University College London

Publications -  37
Citations -  6232

Shyam Kolvekar is an academic researcher from University College London. The author has contributed to research in topics: Pectus excavatum & Myocardial infarction. The author has an hindex of 15, co-authored 37 publications receiving 4822 citations. Previous affiliations of Shyam Kolvekar include St Bartholomew's Hospital & Francis Crick Institute.

Papers
More filters
Journal ArticleDOI

Tracking the Evolution of Non–Small-Cell Lung Cancer

Mariam Jamal-Hanjani, +82 more
TL;DR: Intratumor heterogeneity mediated through chromosome instability was associated with an increased risk of recurrence or death, a finding that supports the potential value of chromosome instability as a prognostic predictor.
Journal ArticleDOI

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Christopher Abbosh, +119 more
- 25 May 2017 - 
TL;DR: It is shown that phylogenetic ct DNA profiling tracks the subclonal nature of lung cancer relapse and metastasis, providing a new approach for ctDNA-driven therapeutic studies.
Journal ArticleDOI

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan, +219 more
- 30 Nov 2017 - 
TL;DR: It is found that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity.
Journal ArticleDOI

Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial

TL;DR: It is shown that adult patients undergoing elective coronary artery bypass graft surgery at a single tertiary centre could benefit from remote ischaemic preconditioning, using transient upper limb ischaemia.
Journal ArticleDOI

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.

TL;DR: Remote ischemic preconditioning did not improve clinical outcomes in patients undergoing elective on-pump CABG with or without valve surgery and there were no significant between-group differences in either adverse events or the secondary end points of perioperative myocardial injury.